LifeSciBench: A Reality Check for AI Agents in the Life Sciences

TL;DR — LifeSciBench shows that current LLMs can help lab communication and structured translation, but they still fail critical artifact‑heavy and exact‑output tasks, so don’t trust them as standalone lab decision agents yet.

What LifeSciBench is and why it matters

LifeSciBench is a 750‑task, expert‑crafted benchmark that tests large language models (LLMs) on realistic life‑science research problems. Unlike trivia or multiple‑choice tests, tasks are written like real lab briefs: free‑text prompts that ask for design thinking, data interpretation, and sometimes the exact generation of sequences or chemical structures.

LifeSciBench targets the real gap: most biology benchmarks are narrow and fact‑based, whereas scientists work with imperfect evidence and decisions.

Key features that change how we should evaluate AI for research:

• Rubric‑based scoring: Every task is split into many atomic criteria so answers earn partial credit rather than one single correct string.
• Artifact‑rich prompts: Over 1,000 attached artifacts — images, tables, sequences, chemical structures, PDFs — and about half of tasks require at least one artifact.
• Realistic complexity: ~79% of tasks need multiple reasoning steps (about four steps on average), mirroring the multi‑stage decisions scientists make.

Methods at a glance

Domain experts authored and validated the benchmark. Here are the core numbers that give it credibility:

• 173 PhD scientists wrote the tasks (biotech/pharma experience).
• 453 independent validators reviewed the tasks (97% hold doctorates), with >96% agreement on relevance and grounding.
• 750 tasks across seven workflows and seven biological domains; 19,020 atomic rubric items (≈25 per task).
• Two scoring metrics: a normalized rubric score (a score that sums checklist items and scales to 0–100) and a task pass if the normalized score ≥ 70% (so partial answers don’t masquerade as success).

Headline results — where the models stand

Five models were tested under one‑shot conditions (one‑turn answers, though internet access was allowed). Domain‑specialized tuning helped, but even the best models passed a minority of tasks.

• Top performer: GPT‑Rosalind led overall, topping 386 of 750 tasks and raising the best‑model pass rate to 36.1% (compared with GPT‑5.5’s 25.7%).
• Notable competitor: Gemini 3.1 Pro uniquely led on 214 tasks, showing that strengths vary by architecture and tuning.
• Partial progress: Models excel where judgment is structured (translation and scientific communication), but struggle with open engineering, analysis, and artifact‑dependent work.

Short sample task to show what “real” looks like

Example prompt: “Given this gel image and sequence file, propose three cloning strategies, explain expected band patterns, and provide exact primer sequences for each strategy.” This mixes visual interpretation, sequence design, and exact outputs — the kind of multi‑step work labs actually need.

Where models fail — the practical chokepoints

LifeSciBench surfaces specific failure modes that matter for deployment in labs and R&D pipelines.

• Interpreting lab artifacts (figures, sequences, chemical structures): Pass rates drop sharply when artifacts are required. GPT‑Rosalind’s pass rate fell from 45.1% on text‑only tasks to 28.1% on artifact tasks; GPT‑5.5 declined from 29.9% to 21.9%.
• Exact sequences and structures: Items requiring precise outputs score poorly — success ranged roughly from 46.9% down to 18.0% across models. Domain tuning barely improved generation/construct items for GPT‑Rosalind versus GPT‑5.5.
• Multi‑step design and analysis: Design/optimization/prediction tasks had low pass rates (GPT‑Rosalind ≈ 30.7%), and analysis tasks were similarly challenged (~30.3%).
• Mid‑task stalls: There were 109 tasks where models earned ≥50% of rubric points yet passed in fewer than 20% of runs — models can get many pieces right but miss decisive checklist items.
• Large headroom for improvement: 171 tasks (22.8%) had no model passes; 261 tasks (34.8%) had best‑model pass rates under 20%.

Rubrics are granular: every task is split into atomic criteria so models can receive partial credit instead of a single correct string.

Business implications for AI agents and lab automation

Benchmarks influence both investment and deployment decisions. LifeSciBench shifts the standard from trivia accuracy to practical competence: can an AI reliably read your lab materials, propose safe protocols, and produce exact sequences when required?

• Do not deploy models as autonomous decision agents: For design, prediction, or artifact‑heavy workflows, current LLMs should not be the final arbiter. Human validation and deterministic checks are essential.
• Use models for structured, low‑risk tasks: Translation, drafting experimental rationales, and scientific communication are useful early targets for automation.
• Focus engineering on artifact grounding: If your pipeline depends on figures, gels, sequences, or structures, invest in multimodal models, better preprocessing (OCR, standardized image metadata), and robust verification subsystems.
• Measure with rubrics, not single answers: Adopt checklist‑style evaluation for vendor selection and ongoing validation. Partial credit is informative, but a high pass threshold (like 70%) should guide deployment readiness.

Limitations and open questions

• One‑shot testing underestimates interactive systems: LifeSciBench used single‑turn evaluations. Multi‑turn agents with human‑in‑the‑loop workflows can recover from mistakes — but they also introduce new risks like error propagation and automation bias.
• Potential bias and stewardship: OpenAI built the benchmark and evaluated several of its own models. That creates a need for independent replications and third‑party evaluations to confirm findings.
• Coverage: 750 tasks are substantial but don’t exhaust every specialty or lab protocol. Local workflows may expose different weaknesses.
• Access and safety: Some artifacts may be gated for safety or licensing reasons, which could limit public replication and community benchmarking.

What leaders should do this quarter

• Run a 20‑task smoke test: Select ~10 artifact‑heavy and ~10 design/analysis tasks from your workflows. Test your preferred LLM in one‑shot and multi‑turn modes and score outputs against a simple rubric.
• Prioritize artifact‑validation engineering: Add deterministic checks for sequences and structures (secondary tools that confirm sequence validity, in‑silico folding sanity checks, unit tests for primer designs).
• Implement human‑in‑the‑loop gates: Define where model recommendations require mandatory human sign‑off, and set up canary tasks to detect drift in deployed agents.
• Adopt rubric scoring for procurement: Require vendors to provide rubric‑scored demos that include artifact use cases, not just text benchmarks.
• Budget for domain specialization: Domain‑tuning helps, but plan for additional investments in multimodal models and validation tooling rather than assuming off‑the‑shelf models are ready.

Next steps and practical help

LifeSciBench is a useful reality check: domain tuning moves the needle, but critical gaps remain around artifact grounding and exact outputs. For teams weighing adoption, practical next steps are straightforward — small validation tests, rubric‑based procurement, and engineering investments that make models verifiable and auditable.

Options to move forward:

• Request a one‑page executive brief mapping LifeSciBench findings to your R&D priorities.
• Run a tailored 20‑task validation suite against your current model and receive a rubric report for decision support.
• Invest in research: multimodal training, deterministic post‑processors for sequence/structure outputs, and robust human‑in‑the‑loop interfaces.

Partial credit is useful — it shows potential — but it isn’t a safety certificate. Treat LLMs as powerful assistants, not final decision makers, until artifact handling and exact‑output reliability improve substantially.